AI Article Synopsis
- Valvular heart disease affects about 1% of pregnancies, posing risks to both the mother and fetus due to pregnancy-related hemodynamic changes.
- Management strategies have evolved with newer techniques and devices to address these challenges, especially concerning anticoagulation in patients with prosthetic valves.
- The review focuses on managing common valvular heart diseases during pregnancy, highlights the role of percutaneous interventions, and emphasizes the need for a collaborative approach while acknowledging existing gaps in research.
Article Abstract
Valvular heart disease is present in about 1% of pregnancies, and it poses a management challenge as both fetal and maternal lives are at risk of complications. Pregnancy is associated with significant hemodynamic changes, which can compromise the cardiac status in women with underlying valvular disorders. Management of valvular heart diseases has undergone considerable innovation and advancement with newer techniques, approaches and devices being employed. The decision regarding the management of anticoagulation, especially in patients with prosthetic valves, raises distinct questions and challenges. In this review, we describe the management of common valvular heart diseases encountered during pregnancy, role of percutaneous catheter based therapeutic interventions, the importance of a team-based approach, and the challenges given existing gaps in the literature.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cpcardiol.2020.100679 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!